Cyclacel Pharmaceuticals Inc (NASDAQ: CYCC) Announces Lung Cancer Study Results

Generally, when a pharmaceuticals or biotech company releases, what the market believes to be, positive results, the stock tends to rise. That was the case with Cyclacel Pharmaceuticals Inc. (NASDAQ: CYCC)...

Could the “Better Botox” From Revance Therapeutics Inc (NASDAQ: RVNC) Be Allergan’s Nemesis?

Shares in already beleaguered Allergan plc (NYSE: AGN) were dealt a body blow Tuesday after Revance Therapeutics Inc (NASDAQ: RVNC) announced favourable results from a pair of phase 3 clinical trials...

Epizyme Had A Volatile Session, and Here’s What You Need to Know…

Epizyme Inc (NASDAQ: EPZM) shares ended up over 10% today, but it was a volatile session for the clinical-stage biopharmaceutical company. The company sold off shortly after the open, after it...

SAGE Therapeutics Inc (NASDAQ: SAGE): Solid Pipeline, Impressive Price Targets

Small-cap biotechnology company SAGE Therapeutics Inc (NASDAQ: SAGE), which suffered a debacle in September 2017 in the late stage trials of its brexanolone (SAGE-547) treatment for experimental super-refractory status epilepticus (SRSE),...
XBIT

Geron (NASDAQ: GERN) Options Activity Indicating A Potential Drop

Geron Corporation (NASDAQ: GERN) sold off nearly 3% today, on above normal trading volume. However, that’s not what caught our attention today. We were focused on the options market, as we...

Abeona Therapeutics: Don’t Be Afraid to Buy the Hype

Over the last couple of months, Abeona Therapeutics stock has ticked up, up, and up. Many investors are questioning whether or not they should actually buy the hype of this stock,...
Celsion

Celsion Shares Up Over 7% After Cancellation of Registered Direct Offering

Celsion Corporation (NASDAQ: CLSN) shares were up over 7% today, after the company announced that it cancelled its registered direct offering of common stock. That said, this action would not dilute...

Two Sides to Corbus Pharmaceutical (NASDAQ: CRBP) Phase II Study Results

Corbus Pharmaceuticals Holdings Inc (NASDAQ: CRBP) shares were down over 10% today, on heavy volume. At one point, the stock was down over 15%. Now, this significant drop may have been...

NewLink Genetics Shares Plummet to Over Five-Year Lows Today, and Here’s What You Need...

NewLink Genetics Corp (NASDAQ:NLNK) shares closed down over 40% today, and NLNK hit levels it hasn’t seen in over five years, following the company’s business update conference call during the pre-market....

What You Need to Know About Clinical Trials for Biotech Stocks

Let’s face it...biotech stocks are difficult to understand when you’re first starting out. Biotech stocks are volatile, and your account could suffer, if you don’t know what you’re looking for or...